RORγt inhibitors as potential back-ups for the phase II candidate VTP-43742 from Vitae Pharmaceuticals: patent evaluation of WO2016061160 and US20160122345.
about
RORγt inhibitors as potential back-ups for the phase II candidate VTP-43742 from Vitae Pharmaceuticals: patent evaluation of WO2016061160 and US20160122345.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
RORγt inhibitors as potential ...... O2016061160 and US20160122345.
@en
RORγt inhibitors as potential ...... O2016061160 and US20160122345.
@nl
type
label
RORγt inhibitors as potential ...... O2016061160 and US20160122345.
@en
RORγt inhibitors as potential ...... O2016061160 and US20160122345.
@nl
prefLabel
RORγt inhibitors as potential ...... O2016061160 and US20160122345.
@en
RORγt inhibitors as potential ...... O2016061160 and US20160122345.
@nl
P2860
P1476
RORγt inhibitors as potential ...... O2016061160 and US20160122345.
@en
P2860
P356
10.1080/13543776.2017.1262350
P407
P577
2016-11-17T00:00:00Z